Effectiveness of pyrazinamide combined with rifampicin and ethambutol in animal experiments
Tynystanova, R.I.; Kozlova, N.V.
Problemy Tuberkuleza 7: 59-63
1984
ISSN/ISBN: 0032-9533 PMID: 6483843 Document Number: 225869
Document emailed within 1 workday
Related Documents
Zieliński, T.; Mosakowska-Glińska, M.; Zalewska-Kubicka, L. 1976: Combined rifampicin and ethambutol treatment of lupus vulgaris of the skin Pneumonologia Polska 44(3): 261-266Thakur, C.P.; Sinha, P.K. 1989: Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar Journal of Tropical Medicine and Hygiene 92(6): 383-385
Kashliaeva, T.K.; Kekcheeva, N.G. 1983: Combined action of penicillin, tetracycline and rifampicin on R. sibirica and R. prowazekii in experiments on chick embryos Antibiotiki 28(4): 285-289
Hoek, K.G.P.; Schaaf, H.S.; Gey van Pittius, N.C.; van Helden, P.D.; Warren, R.M. 2009: Resistance to pyrazinamide and ethambutol compromises MDR/XDR-TB treatment South African Medical Journal 99(11): 785-787
Van Scoy, R.E.; Wilkowske, C.J. 1983: Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide Mayo Clinic Proceedings 58(4): 233-240
Ohno, Y. 2005: Importance of research on alternatives to animal experiments and its current issues: animal experiments in The Japanese Pharmacological Society Nihon yakurigaku zasshi. Folia pharmacologica Japonica 125(6): 325-329
Medoff, G.; Kwan, C.N.; Schlessinger, D.; Kobayashi, G.S. 1973: Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B Cancer Research 33(6): 1146-1149
Araszkiewicz, A.; Miravet, L.; Cohen-Solal, L.; Hioco, D. 1973: Effects of rifampicin and ethambutol on calcium metabolism in the rat Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 167(6): 875-881
Kroening, U. 1983: In vitro studies on the inhibitory effects of rifampicin, pyrazinamide and their combination on mycobacteria with photometric measurement of turbidity Praxis und Klinik der Pneumologie 37(11): 1167-1170
Kozma, D.; Mihalik, P. 1984: Liver and kidney damage in rifampicin and ethambutol treatment Zeitschrift für Erkrankungen der Atmungsorgane 162(3): 249-255
Bialik, I.B.; Klimenko, M.T. 1973: Effect of rifampicin and ethambutol on Mycobacterium tuberculosis in vitro Problemy Tuberkuleza 51(2): 56-61
Skakun, N.P.; Tabachuk, O.E. 1991: Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol Problemy Tuberkuleza 1991(10): 77-79
Salinger, P.L.; Dormer, B.A. 1972: Rifampicin, ethambutol, ethionamide and hydronsan in advanced pulmonary tuberculosis South African Medical Journal 46(13): 354-358
Kozulitsyna, T.I.; Petrov, I.V. 1976: Experimental study of schedules for intermittent administration of rifampicin and ethambutol Problemy Tuberkuleza 5: 72-75
Wozniak, L.; Karasek, M.; Tomaszkiewicz, L.; Sosnowski, W. 1974: Toxic effect of rifampicin and ethambutol on liver in white mice Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 42(9): 925-926
Uvarova, O.A.; Kozulitsina, T.I.; Korotaev, G.A. 1971: Healing processes in experimental tuberculosis treated with rifampicin and ethambutol Problemy Tuberkuleza 49(12): 56-60
Petrova, G.N.; Sedunova, E.A.; Korotaeva, T.A. 1981: Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis Problemy Tuberkuleza 3: 73-74
Camacho, A.; Pérez-Camacho, I.és.; Rivero, A.; Natera, C.; García-Lázaro, M.; Castón, J.J.é; Gallo, M.; Kindelán, J.é M.ía.; Torre-Cisneros, J.án. 2010: Use of rifampicin plus pyrazinamide for antituberculosis prophylaxis does not increase the risk of severe hepatotoxicity in HIV patients: meta-analysis of randomized controlled clinical trials Enfermedades Infecciosas y Microbiologia Clinica 28(4): 239-244
Pinto, M.R.; Arseculeratne, S.N.; Dasan, P.; Uragoda, C.G. 1982: Sensitivity to Ethambutol and Rifampicin of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka Ceylon Medical Journal 27(2): 75-79
Almansa de Cara, S. 1972: Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid) Revista Clinica Espanola 125(4): 353-356